Maqola

Comparative Evaluation of the Antidiabetic Effect of Flavonoids Dihydroquercetin and Thamiflaside

Lubov Kuchkarova¹Department of Human and Animal Physiology, National University of Uzbekistan, Tashkent, UzbekistanKhasan Kayumov¹Department of Human and Animal Physiology, National University of Uzbekistan, Tashkent, UzbekistanK. A. ÉshbakovaInstitute of the Chemistry of Plant Substances, Tashkent, UzbekistanМ. А. АгзамоваInstitute of the Chemistry of Plant Substances, Tashkent, UzbekistanIrodakhon I. KarimovaDepartment of Human and Animal Physiology, National University of Uzbekistan, Tashkent, UzbekistanSevara BerdiyarovaDepartment of Human and Animal Physiology, National University of Uzbekistan, Tashkent, UzbekistanJakhongir AbdurakhmonovDepartment of Human and Animal Physiology, National University of Uzbekistan, Tashkent, UzbekistanRashidbek AchilovDepartment of Human and Animal Physiology, National University of Uzbekistan, Tashkent, UzbekistanUlugbek GayibovInstitute of Bioorganic Chemistry named after A.Sadykov, Tashkent, UzbekistanNurali ErgashevInstitute of Biophysics and Biochemistry, National University of Uzbekistan, Tashkent, Uzbekistan

Trends in Sciencesjournal2025

ABI

Annotatsiya

Diabetes mellitus (DM) is a major global health burden, ranking among the top three diseases leading to disability and mortality. Although some flavonoids exhibit antidiabetic properties, the effects of many remain insufficiently explored. This study investigates the potential of 2 flavonoids—dihydroquercetin (DHQ) and thamiflaside (TF)—to mitigate alloxan-induced diabetes in rats, thereby addressing an important gap in current knowledge. Male rats were divided into 4 groups: Negative control, diabetic (positive control), and two treatment groups receiving either DHQ or TF (30 mg/kg/day, per os) following alloxan induction (50 mg/kg/day, intraperitoneally for 3 days). Alloxan administration resulted in significant hyperglycemia, polydipsia, polyuria, and elevated levels of serum glucose, triglycerides, cholesterol, α-amylase, ALT, and AST, as well as increased maltase and sucrase activity in the small intestinal mucosa. Conversely, levels of insulin, total protein, alkaline phosphatase, and glutathione peroxidase were significantly reduced. DHQ treatment led to marked improvements in fluid balance, glycemic control, lipid profile, enzyme activity in serum, and disaccharidase activity in the intestinal mucosa. Notably, DHQ showed a stronger corrective effect than TF across most parameters. These findings highlight DHQ as a promising candidate for the treatment of diabetes and its associated metabolic disturbances, while also supporting TF as a potential alternative. HIGHLIGHTS Dihydroquercetin (DHQ) and thamiflaside (TF) were tested in alloxan-induced diabetic rats. Alloxan caused hyperglycemia, dyslipidemia, enzyme imbalance, and intestinal disruption. DHQ improved glycemic control, lipid profile, and restored enzymatic activities. TF showed partial correction but weaker efficacy compared to DHQ. DHQ emerges as a stronger candidate for managing diabetes-related metabolic disorders. GRAPHICAL ABSTRACT

Hali tarjima qilinmagan

Mavzular

Natural Antidiabetic Agents Studies Diabetes and associated disorders Metabolism, Diabetes, and Cancer

Identifikatorlar

DOI: 10.48048/tis.2026.11059

Iqtiboslar va manbalar

1 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar · Tez orada